Expression of tumour-suppressing chemokine BRAK/CXCL14 reduces cell migration rate of HSC-3 tongue carcinoma cells and stimulates attachment to collagen and formation of elongated focal adhesions in vitro

Cell Biology International

Volumn 34, Issue 5, 2010, Pages 513-522

  Sato, Kaori ^a,b,c   Ozawa, Shigeyuki ^a   Izukuri, Kazuhito ^a   Kato, Yasumasa ^a   Hata, Ryu Ichiro ^a  

^a KANAGAWA DENTAL COLLEGE   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

BRAK CXCL14; Cell migration; Focal adhesion; Integrin; Rap1

Indexed keywords

ACTIN; COLLAGEN; COLLAGEN TYPE 1; CXCL14 CHEMOKINE; FIBRONECTIN; LAMININ 1; PAXILLIN; RAP1 PROTEIN; VERY LATE ACTIVATION ANTIGEN 2; ALPHA CHEMOKINE; CXCL14 PROTEIN, HUMAN; FOCAL ADHESION KINASE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HYBRID PROTEIN; P21 ACTIVATED KINASE; PROTEIN CDC42; RAC1 PROTEIN; RTKN PROTEIN, HUMAN; SIGNAL PEPTIDE;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CELL ADHESION; CELL CLONE; CELL MIGRATION; CONTROLLED STUDY; FOCAL ADHESION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PROTEIN EXPRESSION; STRESS FIBER; TONGUE CARCINOMA; ANIMAL; CELL COMMUNICATION; CELL MOTION; GENETICS; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TONGUE TUMOR; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; CDC42 GTP-BINDING PROTEIN; CELL ADHESION; CELL COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINES, CXC; COLLAGEN TYPE I; FOCAL ADHESION PROTEIN-TYROSINE KINASES; FOCAL ADHESIONS; HUMANS; INTEGRIN ALPHA2BETA1; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, NUDE; P21-ACTIVATED KINASES; PAXILLIN; RAC1 GTP-BINDING PROTEIN; RAL GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAP1 GTP-BINDING PROTEINS; RECOMBINANT FUSION PROTEINS; TONGUE NEOPLASMS;

EID: 77954756627     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20090108     Document Type: Article

References (32)

1. Arthur WT, Quilliam LA, Cooper JA. Rap1 promotes cell spreading by localizing Rac guanine nucleotide exchange factors. J Cell Biol 2004;167:111-22.
2. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001;47:46-54.
3. Bos JL. Linking Rap to cell adhesion. Curr Opin Cell Biol 2005;17:123-8.
4. Dourdin N, Bhatt AK, Dutt P, Greer PA, Arthur SC, Elce JS, Huttenlocher A. Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J Biol Chem 2001;276:48382-8.
5. Durand CA, Westendorf J, Tse KW, Gold MR. The Rap GTPases mediate CXCL13- and sphingosine1-phosphate-induced chemotaxis, adhesion, and Pyk2 tyrosine phosphorylation in B lymphocytes. Eur J Immunol 2006;36:2235-49.
6. Frederick MJ, Henderson Y, Xu X, Deavers MT, Sahin AA, Wu H et al. In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J Pathol 2000;156:1937-50.
7. Glodek AM, Le Y, Dykxhoorn DM, Park SY, Mostoslavsky G, Mulligan R et al. Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells. Leukemia 2007;21:1723-32.
8. Gu J, Sumida Y, Sanzen N, Sekiguchi K. Laminin-10/11 and fibronectin differentially regulate integrin-dependent Rho and Rac activation via p130Cas-CrkII-DOCK180 pathway. J Biol Chem 2001;276:27090-7.
9. Hromas R, Broxmeyer HE, Kim C, Nakshatri H, Christopherson II K, Azam M, Hou Y-H. Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem Biophys Res Commun 1999;255:703-6.
10. Hogan C, Serpente N, Cogram P, Hosking CR, Bialucha CU, Feller SM et al. Rap1 regulates the formation of E-cadherin-based cell-cell contacts. Mol Cell Biol 2004;24:6690-700.
11. Izukuri K, Suzuki K, Yajima N, Ozawa S, Ito S, Kubota E, Hata R. Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma cell xenografts. Transgenic Res 2010, in press.
12. Kakinuma T, Hwang ST. Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 2006;79:639-51.
13. Kanemitsu N, Ebisuno Y, Tanaka T, Otani K, Hayasaka H, Kaisho T et al. CXCL13 is an arrest chemokine for B cells in high endothelial venules. Blood 2005;106:2613-8.
14. Katagiri K, Maeda A, Shimonaka M, Kinashi T. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat Immunol 2003;4:741-8.
15. Kooistra MRH, Dubé N, Bos JL. Rap1: a key regulator in cell-cell junction formation. J Cell Sci 2007;120:17-22.
16. Krieg C, Boyman O. The role of chemokines in cancer immune surveillance by the adaptive immune system. Semin Cancer Biol 2009:19;76-83.
17. Kurth I, Willimann K, Schaerli P, Hunziker T, Clark-Lewis I, Moser B. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J Exp Med 2001;194:855-61.
18. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 2005;5:505-15.
19. Meuter S, Moser B. Constitutive expression of CXCL14 in healthy human and murine epithelial tissues. Cytokine 2008;44:248-55.
20. Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005;6:56-68.
21. Nara N, Nakayama Y, Okamoto S, Tamura H, Kiyono M, Muraoka M et al. Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. J Biol Chem 2007;282: 30794-803.
22. Ozawa S, Kato Y, Kubota E, Hata R. BRAK/CXCL14 expression in oral carcinoma cells completely suppresses tumor cell xenografts in SCID mouse. Biomed Res 2009a;30:315-18.
23. Ozawa S, Kato Y, Komori R, Maehata Y, Kubota E, Hata R. BRAK/ CXCL14 expression suppresses tumor growth in vivo in human oral carcinoma cells. Biochem Biophys Res Commun 2006;348:406-12.
24. Ozawa S, Kato Y, Ito S, Komori R, Shiiki N, Tsukinoki K et al. Restoration of BRAK/CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma. Cancer Sci 2009b;100:2202-9.
25. Price LS, Hajdo-Milasinovic A, Zhao J, Zwartkruis FJT, Collard JG, Bos JL. Rap1 Regulates E-cadherin-mediated cell-cell adhesion. J Biol Chem 2004;279:35127-32.
26. Raman D, Baugher PJ, Thu YM, Richmond A. Role of chemokines in tumor growth. Cancer Lett 2007;256:137-65.
27. Schaerli P, Willimann K, Ebert LM, Walz A, Moser B. Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. Immunity 2005;23:331-42.
28. Shellenberger TD, Wang M, Gujrati M, Jayakumar A, Strieter RM, Burdick MD et al. BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Cancer Res 2004;64:8262-70.
29. Starnes T, Rasila KK, Robertson MJ, Brahmi Z, Dahl R, Christopherson K et al. The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy. Exp Hematol 2006;34:1101-5.
30. 1 integrin-mediated adhesion to collagen type I by using single-cell force spectroscopy. Mol Biol Cell 2007;18:1634-1644.
31. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987;84:9233-7.
32. Zlotnik A, Yoshie O, Nomiyama H. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 2006;7:243.1-243.11.